Latest news

LATEST NEWS

  • sphingotec raises €20 million from HBM and Wellington Partners

    sphingotec raises €20 million from HBM and Wellington Partners

  • sphingotec is adding an advanced POC testing platform to portfolio

    sphingotec is adding an advanced POC testing platform to portfolio

  • Medical leaders support novel theranostic approach to help patients with leaky blood vessels

    Medical leaders support novel theranostic approach to help patients with leaky blood vessels

  • Ortho Clinical Diagnostics and sphingotec Announce Strategic Agreement Regarding Novel Biomarker for Decreasing Re-hospitalizations in Heart Failure

    Ortho Clinical Diagnostics and sphingotec Announce Strategic Agreement Regarding Novel Biomarker for Decreasing Re-hospitalizations in Heart Failure

  • sphingotec Announces Collaboration with Mayo Clinic for Evaluation and Use of Biomarkers

    sphingotec Announces Collaboration with Mayo Clinic for Evaluation and Use of Biomarkers

  • Review paper on Proenkephalin as a Novel Biomarker for Kidney Function

    Review paper on Proenkephalin as a Novel Biomarker for Kidney Function

  • sphingotec and Shuwen Biotech partner to market sphingotec´s biomarkers portfolio in China

    sphingotec and Shuwen Biotech partner to market sphingotec´s biomarkers portfolio in China

  • sphingotec and bestbion dx partner to market predictive biomarkers for guidance of therapy in acute heart failure and septic shock

    sphingotec and bestbion dx partner to market predictive biomarkers for guidance of therapy in acute heart failure and septic shock

  • Good microcirculation indicates increased lifespan

    Good microcirculation indicates increased lifespan

  • Does the Hormone Neurotensin Hold the Key to a Longer Life?

    Does the Hormone Neurotensin Hold the Key to a Longer Life?

  • Survey: Majority of Women Do Not Discuss Breast Cancer Risks or Mammography Screening Limitations with Healthcare Providers

    Survey: Majority of Women Do Not Discuss Breast Cancer Risks or Mammography Screening Limitations with Healthcare Providers

  • Researchers Link Low Levels of Pro-Enkephalin to Future Breast Cancer in Healthy Women

    Researchers Link Low Levels of Pro-Enkephalin to Future Breast Cancer in Healthy Women

  • Majority of Women Do Not Discuss Breast Cancer Risks with Healthcare Providers

    Majority of Women Do Not Discuss Breast Cancer Risks with Healthcare Providers

  • sphingotec at the St. Gallen International Breast Cancer Conference

    sphingotec at the St. Gallen International Breast Cancer Conference

  • sphingotec and GeneNews Limited/Innovative Diagnostics Laboratory (IDL) Sign a Licensing and Cooperation Agreement for the U.S. Market

    sphingotec and GeneNews Limited/Innovative Diagnostics Laboratory (IDL) Sign a Licensing and Cooperation Agreement for the U.S. Market

Cookie Preference

Please select an option. You can find more information about the consequences of your choice at Help. Privacy Policy | Imprint

Select an option to continue

Your selection was saved!

More information

Help

To continue, you must make a cookie selection. Below is an explanation of the different options and their meaning.

  • Accept all cookies:
    All cookies such as tracking and analytics cookies.
  • Accept first-party cookies only:
    Only cookies from this website.
  • Reject all cookies:
    No cookies except for those necessary for technical reasons are set. Borlabs Cookie already set a necessary cookie.

You can change your cookie setting here anytime: Privacy Policy. Imprint

Back

Top